SCHEMBL22985264

SCHEMBL22985264

Cc1ccccc1-c1ccc2c(c1)c1ccccc1n2-c1ccc(C#N)c(-c2cc(-c3ccc(C(F)(F)F)cc3C#N)ccc2-n2c3ccccc3c3cc(-c4ccccc4C)ccc32)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 7/20 0.44
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
BCAT1 P54687 2/20 0.34
BCAT2 O15382 1/20 0.33
NR3C1 P04150 1/20 0.33
XDH P47989 1/20 0.33
PGR P06401 2/20 0.32
KIF11 P52732 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
PTPN5 P54829 1/20 0.31
FNTA P49354 1/20 0.31
FNTB P49356 1/20 0.31
PGGT1B P53609 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985266 0.97 AR (0.46) ARALOX5APFEN1BCAT1BCAT2
SCHEMBL22985206 0.94 ALOX5AP (0.38) ARALOX5APFEN1NR3C1XDH
SCHEMBL20848882 0.93 AR (0.47) ARBCAT1BCAT2PGR
SCHEMBL22985456 0.93 AR (0.36) ARALOX5APFEN1BCAT1BCAT2
SCHEMBL22985412 0.92 ALOX5AP (0.39) ARALOX5APFEN1NR3C1XDH
SCHEMBL22985416 0.92 ALOX5AP (0.39) ARALOX5APFEN1NR3C1XDH
SCHEMBL22985421 0.92 ALOX5AP (0.39) ARALOX5APFEN1NR3C1XDH
SCHEMBL22985454 0.92 ALOX5AP (0.35) ARALOX5APFEN1BCAT1BCAT2
SCHEMBL22985265 0.92 AR (0.38) ARALOX5APFEN1BCAT1NR3C1
SCHEMBL22985654 0.91 ALOX5AP (0.36) ARALOX5APFEN1BCAT1BCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 AR 3541/4885ALOX5AP 2567/4885FEN1 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.